Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02233348 : Neurocognitive and Psychosocial Outcome of Youths With Autism Spectrum Disorder
PhaseN/A
AgesMin: 10 Years Max: 25 Years
Eligibility
Inclusion Criteria:

ASD participants

1. that they have a clinical diagnosis of autistic disorder or Asperger disorder defined
by the DSM-IV and ICD-10 criteria, made by board-certificated child psychiatrists
and who were clinically diagnosed with ASD confirmed by the ADI-R 7 years ago;

2. their ages range from 10 to 25 (i.e., 3-18 years old at the first assessment);

3. both parents are Han Chinese;

4. who have complete clinical and behavioral data at the 1st assessment;

5. participants and their parents consented to participate in this longitudinal study 7
years ago for complete assessments (3 visits of assessments) at follow-up.

Inclusion Criteria for TD controls, who will be recruited either by school teachers or
from the community, are that they are Han Chinese, consent to the study (if age <18,
parents, too) to complete all the assessments.

Exclusion Criteria:

For TD controls:

1. comorbidity with DSM-IV-TR or DSM-5 diagnoses of ASD, ADHD, schizophrenia,
schizoaffective disorder, delusional disorder, other psychotic disorder, organic
psychosis, schizotypal personality disorder, bipolar disorder, depression, severe
anxiety disorders or substance use;

2. comorbidity with neurological or systemic disorders; and

3. having a first degree relative who may have ASD based on family history method
assessment.
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02233348      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740